US equities |
META $625.60 ▼-0.79% TSLA $405.97 ▲+3.66% MU $932.77 ▲+3.22% NVDA $218.66 ▲+1.23% SPCX $150.92 ▲+2.74% AMD $559.21 ▲+5.26% SNDK $1,315.65 ▲+4.78% INTC $93.98 ▲+3.88%
FinancialContent

Articles published by Invivyd, Inc.

News headline image
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
From Invivyd, Inc.
Via GlobeNewswire
Tickers IVVD
News headline image
Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome
From Invivyd, Inc.
Via GlobeNewswire
Tickers IVVD
News headline image
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Invivyd, Inc.
Via GlobeNewswire
Tickers IVVD
News headline image
Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311
From Invivyd, Inc.
Via GlobeNewswire
Tickers IVVD
News headline image
Invivyd to Participate in Upcoming September Investor Conferences
From Invivyd, Inc.
Via GlobeNewswire
Tickers IVVD